0
0
0
0
1
2
3
$0
Is Solventum solid or fragile? The Finex Financial Health Scanner reads SOLV's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $8.3B |
|---|---|
| Net income | $1.6B |
| Operating margin | 26.2% |
| Net margin | 18.7% |
| Cash and investments | $878.0M |
| Total debt | $5.0B |
| Free cash flow | $201.8M |
| Revenue growth (1 year) | 0.9% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.